[Clinical analysis of blood ammonia levels for predicting survival following transjugular intrahepatic portosystemic shunt in patients with cirrhosis] [0.03%]
血氨水平对肝硬化患者经颈静脉肝内门体分流术预后的临床分析
Y Liu,F Zhang,Q Yin et al.
Y Liu et al.
Objective: To assess the blood ammonia levels value for predicting survival following transjugular intrahepatic portosystemic shunt (TIPS) therapy in patients with cirrhosis. Methods: Data from 236 cirrhotic patients who underwent TIPS trea...
[Comparison of antiviral efficacy of nucleos(t)ide analogue monotherapy and its combination with interferon-α in children 1-6 years-old with HBeAg-positive chronic hepatitis B] [0.03%]
替比夫定或拉米夫定单药与联合干扰素α治疗1-6岁乙肝e抗原阳性慢性乙型肝炎患儿的疗效比较
Z W Wang,Y Dong,W X Ouyang et al.
Z W Wang et al.
Objective: To explore the antiviral efficacy and safety profile of nucleos(t)ide analogue (NA) mono-or combination therapy with interferon-α (IFN-α) in children 1-6 years old with hepatitis B e antigen (HBeAg)-positive chronic hepatitis B...
[Towards precision diagnosis and treatment: interpretation of the ten highlights of the expert consensus on the diagnosis and treatment of hereditary hyperbilirubinemia (version 2025)] [0.03%]
向精准诊断与治疗迈进——遗传性高胆红素血症诊治专家共识（2025年版）十问解读
W Hou,Z P Duan,S J Zheng
W Hou
To assist relevant clinicians specializing in liver diseases in making informed decisions regarding the diagnosis and treatment of hereditary hyperbilirubinemia, the Inherited and Metabolic Liver Disease Cooperative Group of the Hepatology ...
[Expert consensus on the diagnosis, treatment, and management of liver nodules (version 2026)] [0.03%]
[肝结节的诊断、治疗和管理专家共识（2026版）]
Infectious Diseases Prevention and Control Branch, Chinese Preventive Medicine Association
Infectious Diseases Prevention and Control Branch
Liver nodules are one of the common and complex clinical conditions, with certain ones developing into malignant lesions, hence significantly affecting patient prognosis. The detection rate of liver nodules has significantly improved with a...
[Expert consensus on overall standardized management of gadoxetate disodium-enhanced MRI examinations (version 2026)] [0.03%]
[ gadobenate二钠增强MRI检查全流程规范化管理专家共识(2023年版)]
Abdomen Group of Chinese Society of Radiology, Chinese Medical Association;Nursing Group of Chinese Society of Imaging Technology, Chinese Medical Association;Chongqing Society of Radiology et al.
Abdomen Group of Chinese Society of Radiology et al.
Gadoxetate disodium (Gd-EOB-DTPA), as a hepatocyte-specific MRI contrast agent, plays a key role in the early-stage diagnosis, differential diagnosis, and treatment evaluation of liver diseases. Gd-EOB-DTPA-enhanced MRI has been recommended...
[Chinese expert consensus on the use of standardized second-line drugs for primary hepatocellular carcinoma] [0.03%]
中国原发性肝癌经动脉化疗栓塞治疗后应用标准化二线药物治疗专家共识
Translational Medicine Branch, China Association of Gerontology and Geriatrics;Society of Hepatology, Beijing Medical Association;Expert Committee on Liver Cancer et al.
Translational Medicine Branch et al.
With the rapid development of systemic therapy for primary hepatocellular carcinoma, how to scientifically formulate subsequent treatment strategies following first-line treatment failure has become a key issue that urgently needs to be add...
[Expert consensus on the management process within medical institutions for patients with hepatitis B virus infection] [0.03%]
《乙型肝炎病毒患者院内管理流程专家共识》
Author Group of Expert Consensus
Author Group of Expert Consensus
In order to effectively utilize hepatitis B information obtained during routine health checkups, a panel of experts from clinical medicine, public health, laboratory testing, and methodology reviewed the latest research findings in guidelin...
S Tang,W Hou,Z P Duan et al.
S Tang et al.
Y Zhi,Y N Dong,X H Lei et al.
Y Zhi et al.